Adrian Chung

Adrian Chung, MBA, CA is currently the Director of Product & Program Management at DELFI Diagnostics, where Adrian leads the Liver cancer portfolio of Fragmentomic molecular tests. Adrian has a strong background in life sciences and healthcare strategy and product commercialization, having founded Adrian Chung Consulting. Prior to their current role, Adrian worked at companies like Visby Medical, Thermo Fisher Scientific, and Viacom, where Adrian held various leadership positions in product management, strategy, and marketing. Adrian has a diverse educational background, holding degrees in finance, management, accountancy, and human/medical genetics from institutions like Northwestern University, CEIBS, ICAEW, and UCL.